![Joachim Sieper, Désirée van der Heijde, Maxime Dougados, L Steve Brown,Frederic Lavie, Aileen L Pangan Ann Rheum Dis 2012;71: doi: /annrheumdis ppt download Joachim Sieper, Désirée van der Heijde, Maxime Dougados, L Steve Brown,Frederic Lavie, Aileen L Pangan Ann Rheum Dis 2012;71: doi: /annrheumdis ppt download](https://slideplayer.com/10989360/39/images/slide_1.jpg)
Joachim Sieper, Désirée van der Heijde, Maxime Dougados, L Steve Brown,Frederic Lavie, Aileen L Pangan Ann Rheum Dis 2012;71: doi: /annrheumdis ppt download
Désirée van der Heijden - Coach / Vertrouwenspersoon / Trainer / Acteur in training - Deezs | Theater & Communicatie | LinkedIn
![Assessment in Ankylosing Spondylitis International Working Group/Spondylitis Association of America recommendations for conducting clinical trials in ankylosing spondylitis - van der Heijde - 2005 - Arthritis & Rheumatism - Wiley Online Library Assessment in Ankylosing Spondylitis International Working Group/Spondylitis Association of America recommendations for conducting clinical trials in ankylosing spondylitis - van der Heijde - 2005 - Arthritis & Rheumatism - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/62344b51-0763-48b2-9115-5a12a651380e/art.20790.fp.png)
Assessment in Ankylosing Spondylitis International Working Group/Spondylitis Association of America recommendations for conducting clinical trials in ankylosing spondylitis - van der Heijde - 2005 - Arthritis & Rheumatism - Wiley Online Library
![EULAR 2022 | The BE MOBILE 1 and 2 trials of bimekizumab in axSpA | rheumatology.medicinematters.com EULAR 2022 | The BE MOBILE 1 and 2 trials of bimekizumab in axSpA | rheumatology.medicinematters.com](https://i.ytimg.com/vi/UDURz_ZjJ4M/maxresdefault.jpg)
EULAR 2022 | The BE MOBILE 1 and 2 trials of bimekizumab in axSpA | rheumatology.medicinematters.com
![PDF) Effects of baricitinib on radiographic progression of structural joint damage at 1 year in patients with rheumatoid arthritis and an inadequate response to conventional synthetic Disease-Modifying antirheumatic drugs PDF) Effects of baricitinib on radiographic progression of structural joint damage at 1 year in patients with rheumatoid arthritis and an inadequate response to conventional synthetic Disease-Modifying antirheumatic drugs](https://i1.rgstatic.net/publication/325013650_Effects_of_baricitinib_on_radiographic_progression_of_structural_joint_damage_at_1_year_in_patients_with_rheumatoid_arthritis_and_an_inadequate_response_to_conventional_synthetic_Disease-Modifying_ant/links/5af19990458515c2837555b3/largepreview.png)